Results 1 to 10 of about 39,626 (160)

Application and interpretation of immunophenotyping data in safety and risk assessment

open access: yesFrontiers in Toxicology
The use of immunophenotyping during immunotoxicity investigations was first popularized in the 1980 s and has since become more integrated into diagnostic and non-clinical assessments.
Victor J. Johnson   +7 more
exaly   +3 more sources

Immunophenotyping

open access: yes
Citation: 'immunophenotyping' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13309 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms. Requests
Herold NC, Zubair M, Mitra P.
europepmc   +2 more sources

Carboxypeptidase A3—A Key Component of the Protease Phenotype of Mast Cells

open access: yesCells, 2022
Carboxypeptidase A3 (CPA3) is a specific mast cell (MC) protease with variable expression. This protease is one of the preformed components of the secretome.
Dmitri Atiakshin   +5 more
doaj   +1 more source

Role of immunophenotyping in diagnosis of CLL patient at South Egypt Cancer Institute [PDF]

open access: yesMinia Journal of Medical Research, 2020
Objective: To determine the role of immunophenotyping in chronic lymphocytic leukemia (CLL) patients at South Egypt Cancer Institute (SECI). Methodology: This study was carried out in Department of Clinical pathology, South Egypt Cancer Institute, from ...
Rana Nagieb   +3 more
doaj   +1 more source

Mast Cells in Regeneration of the Skin in Burn Wound with Special Emphasis on Molecular Hydrogen Effect

open access: yesPharmaceuticals, 2023
The mechanisms of regeneration for the fibrous component of the connective tissue of the dermis are still insufficiently studied. The aim of this study was to evaluate the effectiveness of the use of molecular hydrogen on the local therapy of a II degree
Dmitri Atiakshin   +8 more
doaj   +1 more source

Mast Cells as a Potential Target of Molecular Hydrogen in Regulating the Local Tissue Microenvironment

open access: yesPharmaceuticals, 2023
Knowledge of the biological effects of molecular hydrogen (H2), hydrogen gas, is constantly advancing, giving a reason for the optimism in several healthcare practitioners regarding the management of multiple diseases, including socially significant ones
Dmitri Atiakshin   +8 more
doaj   +1 more source

Immunophenotyping of Tumours [PDF]

open access: yesMedical Journal Armed Forces India, 2008
Immunophenotyping has added a new dimension to improve the diagnostic accuracy of malignant diseases. The emphasis is on its usefulness in planning and institution of specific therapy besides helping in prognostication.The study included 83/1385 biopsies of cancer patients over an 18 month period on which immunohistochemical staining (IHC) with ...
R, Lakhtakia, S K, Nema
openaire   +2 more sources

Immunophenotyping beyond the limits of time

open access: yesCell Reports: Methods, 2023
Immunophenotyping is a powerful approach for deciphering responses of the immune system to drug screening and immunotherapy. In this issue of Cell Report Methods, Liechti et al.
J. Fréderique de Graaf, Ramon Arens
doaj   +1 more source

The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders

open access: yesBritish Journal of Biomedical Science, 2023
Background: B-Cell Lymphoproliferative Disorders (B-LPDs) are a group of heterogenous disorders characterised by the accumulation of B-cells in peripheral blood, bone marrow, lymph nodes and spleen.
Hanaan Kareem Al-Zubaidi   +1 more
doaj   +1 more source

Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay

open access: yesFrontiers in Oncology, 2020
Undetectable minimal residual disease (MRD) in Chronic Lymphocytic Leukemia (CLL) has a favorable prognostic outcome compared with MRD that can be detected.
Timothy W. Farren   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy